Showing results (1571-1580 of 2,996) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|January 1, 1997
Pharmacokinetic properties of LMW-heparin-tyramine fractions with high or low affinity to antithrombin III in the ratG Stehle, A Wunder, H Sinn, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Heparin in patients with venous thromboembolism and contraindications to oral anticoagulant therapyM MonrealSeminars in Thrombosis and Hemostasis|January 1, 1997
Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementationJ T Owings, R GosselinSeminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin interaction with platelet membrane glycoprotein IbM Jandrot-Perrus, M C Bouton, F Lanza, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
A family of arginal thrombin inhibitors related to efegatranG F Smith, R T Shuman, T J Craft, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Modulation of venous endothelial activity and transcellular calcium transport by defibrotide: the adenosine hypothesisF L Pasini, C Frigerio, P L Capecchi, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Pathophysiology of thromboembolism and its modulation by low-molecular-weight heparinsH K BreddinSeminars in Thrombosis and Hemostasis|January 1, 1996
An integrated view of the activities of defibrotideR Pescador, R Porta, L FerroSeminars in Thrombosis and Hemostasis|January 1, 1995
Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiencyM Dreyfus, M Masterson, M David, et al.Seminars in Thrombosis and Hemostasis|January 1, 1995
Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIIIW Kreuz, S Becker, E Lenz, et al.Pageof 300